BackStatera BioPharma Overview

Statera BioPharma Total Assets

Track Statera BioPharma's total assets ($13M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$12.75M
87.00% YoYΔ $-85.29M vs prior year quarter

Peer average

Loading

Statera BioPharma Total Assets History

Loading

Statera BioPharma vs. peers: Total Assets Comparison

Loading

Statera BioPharma Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Statera BioPharma (STAB) FAQ

As of the most recent data (September 2022), STAB shows a total assets of $13M. That compares with $98M in the prior-year period — down 87.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, STAB's total assets is now $13M (was $98M) — a 87.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Statera BioPharma is outperforming or lagging.

Tracking STAB's total assets over time shows whether Statera BioPharma is scaling, shrinking, or reshaping that part of the business. The current reading is $13M That compares with $98M in the prior-year period — down 87.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Statera BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $13M) with ownership activity and broader fundamentals.

Statera BioPharma's total assets is $13M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.